Optimal length of time of cryopreserved umbilical cord blood infusion after thawing
Authors:
- 25 November 2013
- journal article
- Published by Taylor & Francis in Hematology
- Vol. 19 (2) , 73-79
Abstract
Dimethyl sulfoxide (DMSO) can damage hematopoietic progenitor cells (HPCs) at room temperature. To minimize the time of contact between DMSO and the thawed umbilical cord blood (UCB), there is an incentive to infuse the UCB as quickly as possible. However, the infusion of cryopreserved UCB also results in side effects. Currently, it is difficult to determine the optimal length of time for cryopreserved UCB infusion, not only to ensure the maximum effect of engraftment but also to reduce the toxicity of the cord blood infusion. Ten units of cord blood were thawed to assess viability, apoptotic events of CD34(+) cells and CD45(+) cells, and the number of colony-forming units (CFUs) at four time points: 0, 10, 20, and 30 minutes post-thaw (PT). The infusion time, side effects, and the speed of platelet and neutrophil engraftment of the 10 patients were monitored. Within 30 minutes, the viability decreased (P < 0.01), the percentage of early apoptotic CD34(+) cells and CD45(+) cells was unchanged. At time point PT30, the number of CFUs was decreased compared to PT0 (P < 0.05), but it was unchanged within 20 minutes. All the 10 UCB cells engrafted well in patients. This study indicates that post-thawed UCB HPCs are preserved for less than 30 minutes at room temperature; thus, the optimal length of time of cryopreserved cord blood infusion should be no more than 20 minutes after thawing.Keywords
This publication has 23 references indexed in Scilit:
- Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftmentTransfusion, 2011
- Acute life‐threatening cardiovascular toxicity with umbilical cord blood infusion: The role of dextranAmerican Journal of Hematology, 2010
- 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSOTransfusion, 2010
- Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomesBlood, 2008
- Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology groupBone Marrow Transplantation, 2008
- Cardiovascular toxicity of cryopreserved cord blood cell infusionBone Marrow Transplantation, 2008
- Coronary artery spasm after infusion of cryopreserved cord blood cellsBone Marrow Transplantation, 2007
- Apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood detected by the fluorescent vital dye SYTO 16 and correlation with loss of L-selectin (CD62L) expressionBone Marrow Transplantation, 2006
- Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrowBone Marrow Transplantation, 2004
- Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftmentBone Marrow Transplantation, 2003